13 Nov
Pfizer just did it again!
After a few weeks of sleeping inside that weekly demand imbalance, the pharmaceutical giant exploded — exactly as expected from our supply and demand forecast. Price has already rallied more than 7%, proving once again how powerful these imbalances can be when you learn to read them properly. Let’s dive into the charts and break down what’s happening with Pfizer stock!
Pfizer Weekly Supply & Demand Update – November 2025
Pfizer $PFE reacted beautifully to the weekly demand imbalance we highlighted in our last analysis. That blue zone between $24.39 and $23.58 became the turning point where buyers took full control.
The imbalance created weeks ago produced a strong bullish candle—the largest in months—a clear footprint of institutional demand. Since then, price has confirmed what we expected: a clean 7% rally off the weekly demand.
This is a textbook example of patience paying off.
While most traders were chasing news headlines and speculating on Pfizer’s fundamentals, all we had to do was wait for price to pull back to demand and let the imbalance do its work. No indicators, no earnings, no news. Just price action and pure supply and demand mechanics.
What’s next for Pfizer stock?
If momentum continues, Pfizer could easily head toward the next weekly supply imbalance in the $27–$28 area. Until that happens, this weekly demand zone remains in full control.
Remember — price action always tells the truth. Fundamentals are already priced in; imbalances are the footprints of institutional orders, and it’s those that really move markets.
And for those who thought Pfizer was “done” after months of sideways pain — well, the chart just prescribed them a healthy dose of humility. Always listen to the imbalances, not the headlines! 😄
Key Takeaways
- Weekly demand at $24.39–$23.58 held perfectly.
- Price has rallied 7% since touching demand.
- Demand remains in control; no new supply imbalances have taken over.
- The next reaction could occur near the $27–$28 area if the rally continues.
- This is the power of supply and demand — no news, no noise, just logic.
Pfizer’s Big Move Explained for Kids!
November 13, 2025
META Platforms Crashes $100! Guess Who Sold Before the Drop…
November 3, 2025
Why is EURGBP Forex rallying?
October 31, 2025
Pfizer’s $PFE Demand Zone — Ready to Explode?
October 28, 2025
Should You Buy Tesla Stock Right Now After a Strong Rally?
October 21, 2025
© 2013 – 2025
Set and Forget S.L
All Rights Reserved.
Follow Us
Disclaimer
Any Advice or information on this website is General Advice Only - It does not take into account your personal circumstances, please do not trade or invest based solely on this information. By viewing any material or using the information within this site you agree that this is general education material and you will not hold any person or entity responsible for loss or damages resulting from the content or general advice provided here by Set and Forget, its employees, or fellow members. Futures, options, and spot currency and stocks trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the Forex and futures markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell spot Forex, cfd's, stocks or other financial products. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in any material on this website. The past performance of any trading system or methodology is not necessarily indicative of future results.
High Risk Warning: Forex, Futures, and Options trading has large potential rewards, but also large potential risks. The high degree of leverage can work against you as well as for you. You must be aware of the risks of investing in Forex, futures, and options and be willing to accept them in order to trade in these markets. Forex trading involves substantial risk of loss and is not suitable for all investors. Please do not trade with borrowed money or money you cannot afford to lose. Any opinions, news, research, analysis, prices, or other information contained on this website is provided as general market commentary and does not constitute investment advice. We will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from the use of or reliance on such information. Please remember that the past performance of any trading system or methodology is not necessarily indicative of future results.